Correlation Between VistaGen Therapeutics and Thermo Fisher

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Thermo Fisher at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Thermo Fisher into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Thermo Fisher Scientific, you can compare the effects of market volatilities on VistaGen Therapeutics and Thermo Fisher and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Thermo Fisher. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Thermo Fisher.

Diversification Opportunities for VistaGen Therapeutics and Thermo Fisher

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between VistaGen and Thermo is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Thermo Fisher Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Thermo Fisher Scientific and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Thermo Fisher. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Thermo Fisher Scientific has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Thermo Fisher go up and down completely randomly.

Pair Corralation between VistaGen Therapeutics and Thermo Fisher

Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 4.9 times more return on investment than Thermo Fisher. However, VistaGen Therapeutics is 4.9 times more volatile than Thermo Fisher Scientific. It trades about 0.3 of its potential returns per unit of risk. Thermo Fisher Scientific is currently generating about 0.4 per unit of risk. If you would invest  225.00  in VistaGen Therapeutics on October 20, 2024 and sell it today you would earn a total of  67.00  from holding VistaGen Therapeutics or generate 29.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.0%
ValuesDaily Returns

VistaGen Therapeutics  vs.  Thermo Fisher Scientific

 Performance 
       Timeline  
VistaGen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VistaGen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, VistaGen Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Thermo Fisher Scientific 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Thermo Fisher Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Thermo Fisher is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

VistaGen Therapeutics and Thermo Fisher Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VistaGen Therapeutics and Thermo Fisher

The main advantage of trading using opposite VistaGen Therapeutics and Thermo Fisher positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Thermo Fisher can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will offset losses from the drop in Thermo Fisher's long position.
The idea behind VistaGen Therapeutics and Thermo Fisher Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets